Health Care & Life Sciences » Biotechnology | EXACT Sciences Corp.

EXACT Sciences Corp. | Mutual Funds

Mutual Funds that own EXACT Sciences Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PRIMECAP Odyssey Aggressive Growth Fund
3,067,900
2.5%
0
2.04%
06/30/2018
Vanguard Small Cap Index Fund
3,066,740
2.5%
38,939
0.24%
07/31/2018
Vanguard Total Stock Market Index Fund
3,061,305
2.49%
3,220
0.03%
07/31/2018
Oppenheimer Global Opportunities Fund
2,500,000
2.04%
0
2%
03/31/2018
Vanguard Small Cap Growth Index Fund
1,751,081
1.43%
25,951
0.51%
07/31/2018
Vanguard Extended Market Index Fund
1,619,927
1.32%
0
0.17%
07/31/2018
Fidelity Select Biotechnology Portfolio
1,460,400
1.19%
-43,800
1.19%
07/31/2018
Oppenheimer Main Street Fund
1,179,870
0.96%
1,179,870
0.84%
02/28/2018
SPDR S&P Biotech ETF
1,160,016
0.95%
2,985
1.48%
09/06/2018
Government Pension Fund - Global (The)
1,143,429
0.93%
-742,793
0.01%
12/31/2017

About EXACT Sciences

View Profile
Address
441 Charmany Drive
Madison Wisconsin 53719
United States
Employees -
Website http://www.exactsciences.com
Updated 07/08/2019
EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It has an intellectual property, which protects its non invasive, molecular screening technology for the detection of colorectal cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.